The relationship between breast self examination (BSE) and breast cancer stage at diagnosis was examined in 616 women aged 15-59 years. Differences in tumour characteristics between those not practising BSE and those practising but not taught were small and inconstant. However, women who had both practised and had been taught BSE had more favourable tumours than the non-practising group. The difference was most marked in terms of tumour size and the involvement of axillary nodes. The proportions of women in the non-BSE and taught-BSE groups with each characteristic were respectively: size <2cm 33% and 45%, T1 clinical stage 27% and 42%, and No pathological stage 37% and 50%. This advantage to taught-BSE women persisted after adjustment for the identified confounding factors of age, social class and oral contraceptive use. The likely impact on breast cancer mortality is difficult to assess, although the potential benefit of the lead time gained must not be ignored when assessing the costs and benefits of BSE.
The promising results of the recently reported Swedish trial of mammography (Tabar et al., 1985) , and the subsequent discussion of the need for widespread population screening, have encouraged critical review of the available methods for the early detection of breast cancer. Breast self examination (BSE) has not escaped scrutiny, and a number of recent articles have stressed its disadvantages and emphasised the limited evidence for its effectiveness. Frank and Mai (1985) , for example, argue that BSE may lead to unwarranted anxiety, to the risk of false reassurance, and to unnecessary medical investigation, particularly in younger women. Unfortunately, no randomised controlled trial of the effect of BSE on the prognosis of breast cancer is available; it is, however, possible to assess whether BSE leads to the diagnosis of breast cancer at an earlier stage. This, of course, is neither a sufficient, nor strictly a necessary, condition for a reduction in mortality, although the case for BSE would be difficult to sustain if no effect on stage at diagnosis could be demonstrated.
This question has been approached by a number of investigators. An early study by Greenwald et al. (1978) compared stage at diagnosis in cancers detected by BSE, by physician examination and by 'accident'. However, as the ability of a woman to detect a breast lump 'accidentally' is obviously not independent of her practice of regular systematic BSE, subsequent studies have compared stage at diagnosis of self-discovered cancers in women who report practising systematic BSE and in those who do not, irrespective of how the cancer was detected. The difficulty of defining 'systematic BSE' retrospectively, and the existence of confounding factors, must explain some of the variation in the results. Thus, three centres in the United States have reported case series in which BSE has been associated with favourable tumour characteristics and earlier stage at diagnosis (Foster et al., 1978; Feldman et al., 1981; Huguley and Brown 1981; Foster & Constanza, 1984) , while conversely, two case series have been presented in which no significant advantage was demonstrated (Smith et al., 1980; Senie et al., 1981) . We report findings from our own study here. specially trained nurses as part of a large case-control study of the relationship between reproductive factors and breast cancer Vessey et al., 1983) . Some of these patients had attended only the hospital at which they were interviewed, while others had been referred in for radiotherapy from other hospitals in the London area.
Subjects and methods

Between
Each woman was asked about her medical, gynaecological, obstetric, menstrual, contraceptive and social history. In addition, the opportunity was taken to make enquiries about who discovered the breast tumour and about whether or not the woman normally practised BSE. Those responding positively were asked whether or not they had been taught how to do BSE and how often they examined themselves. Women were not asked to demonstrate their proficiency at BSE.
Subsequently, the case notes of each patient with cancer were reviewed by a nurse and pre-operative clinical information was abstracted to enable the tumour to be staged according to the TNM system (International Union Against Cancer, 1968) . When different parts of the clinical record reported different findings, those which were least favourable were noted. Records made by medical students (when recognisable as such) were ignored unless it was clear that they were endorsed by a doctor. The nurse concerned with the review (Moya Simmonds) had been carefully instructed by one of us (M.V.) and a series of case-notes had been doublecoded (i.e. by M.V. and M.S.) to ensure that the work was done as accurately as possible. The record review was done many months after the interview had been completed, and the interview data were not available to the abstractor. The nurse also abstracted the pathological records (a) to confirm that the lesion was indeed malignant and (b) to discover whether or not there was histological evidence of axillary node involvement. Information recorded by the pathologist was not, of course, taken into account in the clinical staging.
A total of 747 women was interviewed. Of these 44 (5.9%) were excluded from the analysis because the cancer had been discovered by someone other than the woman herself. Staging information was obtained for 616 (87.1%) of the remaining 707 women. Our failure to obtain the necessary information for 91 women was due in part to missing case notes and in part to inadequate clinical information in some of the notes which were found. There were however, no important differences between the 616 women for whom staging was completed and the 91 women for whom it was not with regard to BSE history, age, oral contraceptive use or social class.
Results
The relationship between the BSE history given by the G The discrepancy in the results for T1 tumours and for Stage 1 tumours reflects the fact that the effect of BSE is primarily on the T1/T2 ratio -i.e. the increase in T1 tumours is compensated for by a reduction in T2 tumours rather than in T3 or T4 tumours. Table V . Although there is some reduction in the association between BSE and favourable clinical tumour characteristics, the data for size and for proportion of T1 tumours remain encouraging and the trends are highly significant statistically. The figures also suggest a small advantage of BSE in relation to axillary nodal status assessed clinically. The data concerning the histopathological assessment of the axillary nodes continue to indicate a strong beneficial association with BSE.
Discussion
The clinical findings reported here depend on the staging of tumours retrospectively from the data recorded in case notes, a procedure which is known to be inaccurate. In a previous study, however, using identical methods, we found case record based staging to provide a good indication of prognosis (see Greenberg et al., 1985) . Thus, in a series of and now practise BSE are for other reasons likely to present with more favourable tumours than other women), but the association remains after adjustment for identified confounding factors. Moreover, the case for a causal relationship is supported by the demonstration of an incremental effect of increasing degrees of implied effectiveness of BSE on the strength of the association. Having said this, it must be noted that the effect we have observed on clinical stage, although highly significant statistically, is nonetheless modest.
The results presented on the histopathological status of the axillary nodes are even more encouraging, although here too there must be some reservations about the adequacy of the data. The greater apparent effect on histologically assessed as against clinically assessed nodal status presumably reflects the inaccuracy of the clinical staging method. This histological data suggest that properly taught BSE could lead to a reduction of the order of 20-30% in the number of women presenting with positive axillary nodes at the time of diagnosis. It is plausible that an improvement in nodal status of this magnitude could be associated with an important increase in survival.
Our results are consistent with the five comparable studies reported since 1980 of which we are aware, bearing in mind that the definition of BSE and the non-BSE comparison group has been inconsistent. The proportions of tumours <2cm (or <2 cm) in BSE and non-BSE groups in each study, defining the BSE group as women who practice BSE at least yearly (Huguley & Brown, 1981) , several or more times yearly (Feldman et al., 1981) , ever (Foster & Constanza, 1984) , at least three times a year (Smith et al., 1980) , and at least monthly (Senie et al., 1981) were respectively 47% vs. 37%, 56% vs. 39%, 42% vs. 23%, 23% vs. 22% and 48% vs. 43%. In the last two studies the observed difference did not reach statistical significance. Two studies of different design from the United Kingdom, reporting the effect of a BSE booklet (Turner et al., 1984) and BSE instruction (Philip et al., 1984) , also described a reduction in tumour size in the intervention group. The failure to show a significant reduction in tumour size by Smith et al. may be explained by the limited number of women (127) upon whom the analysis was based. The study by Senie et al. contained a high proportion (9%) of microscopic tumours.
All the studies mentioned also reported axillary node status based on pathological information. The degree of ascertainment of nodal status varied (and was not reported by Smith et al. and Feldman et al.) . The proportions of women with positive axillary nodes in BSE and non-BSE groups (using the same definitions as before) were respectively 43% and 50% (Huguley & Brown, 1981) , 46% and 61% (Feldman et al., 1981) , 39% and 56% (Foster & Constanza, 1984) , 36% and 42% (Senie et al., 1981) , and 41% and 42% (Smith et al., 1980) . As before, the observed difference in the latter two studies was not statistically significant.
Our conclusion is that BSE, after adequate teaching, does lead to earlier diagnosis. The clinical importance of this lead time is hard to assess, but we are following up all the women in our study and will be able to report on survival in due course. There is no doubt that the specificity of BSE as a screening test is low and the costs in terms of false positive results, anxiety, suffering and use of medical resources may be high. The important question now is not whether BSE advances diagnosis, but whether the benefit is sufficient to outweigh the human and resource costs.
